Cabot Corporation
General ticker "CBT" information:
- Sector: Materials
- Industry: Chemicals - Specialty
- Capitalization: $3.9B (TTM average)
Cabot Corporation follows the US Stock Market performance with the rate: 18.6%.
Estimated limits based on current volatility of 1.9%: low 86.29$, high 89.63$
Factors to consider:
- Company pays dividends (quarterly): last record date 2026-05-29, amount 0.47$ (Y2.20%)
- Total employees count: 4200 (-2.3%) as of 2024
- China accounted for 24.6% of revenue in the fiscal year ended 2024-09-30
- US accounted for 18.4% of revenue in the fiscal year ended 2024-09-30
- Top business risk factors: Operations in china, Market competition, Regulatory and compliance, Geopolitical risks, Operational and conduct risks
- Price in estimated range
- Earnings for 6 months up through Q2 are close to our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-09-30 to 2027-09-30
- 2025-09-30 to 2026-09-30 estimated range: [61.43$, 89.59$]
- 2026-09-30 to 2027-09-30 estimated range: [64.21$, 92.99$]
Financial Metrics affecting the CBT estimates:
- Negative: with PPE of 10.6 at the end of fiscal year the price was high
- Positive: Operating cash flow per share per price, % of 16.16 > 12.90
- Positive: 7.54 < Operating profit margin, % of 16.73
- Positive: 19.24 < Shareholder equity ratio, % of 40.63 <= 42.59
- Negative: Industry operating cash flow per share per price (median), % of 4.88 <= 5.46
- Positive: Return on assets ratio (scaled to [-100,100]) of 8.82 > 6.06
Short-term CBT quotes
Long-term CBT plot with estimates
Financial data
| YTD | 2023-09-30 | 2024-09-30 | 2025-09-30 |
|---|---|---|---|
| Operating Revenue | $3,931.00MM | $3,994.00MM | $3,713.00MM |
| Operating Expenses | $3,405.00MM | $3,380.00MM | $3,092.00MM |
| Operating Income | $526.00MM | $614.00MM | $621.00MM |
| Non-Operating Income | $-70.00MM | $-85.00MM | $-56.00MM |
| Interest Expense | $90.00MM | $81.00MM | $76.00MM |
| R&D Expense | $57.00MM | $63.00MM | $59.00MM |
| Income(Loss) | $456.00MM | $529.00MM | $565.00MM |
| Taxes | $-28.00MM | $111.00MM | $196.00MM |
| Other Income(Loss) | $5.00MM | $6.00MM | $7.00MM |
| Net Income(Loss)* | $445.00MM | $380.00MM | $331.00MM |
| Stockholders Equity | $1,264.00MM | $1,425.00MM | $1,550.00MM |
| Inventory | $585.00MM | $552.00MM | $504.00MM |
| Assets | $3,604.00MM | $3,736.00MM | $3,815.00MM |
| Operating Cash Flow | $595.00MM | $692.00MM | $665.00MM |
| Capital expenditure | $244.00MM | $241.00MM | $274.00MM |
| Investing Cash Flow | $-214.00MM | $-235.00MM | $-298.00MM |
| Financing Cash Flow | $-403.00MM | $-415.00MM | $-336.00MM |
| Earnings Per Share** | $8.06 | $7.00 | $6.16 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.